Key result
Lipoprotein buoyancy and inflammatory markers improve cardiovascular risk prediction over total lipoprotein levels alone.
Answers are grounded in this paper and cite their sources.
The vital task of evaluating cardiovascular disease risk in individual patients is challenging in light of the ever-growing list of risk factors. Some of the traditional measures of cardiovascular risk, such as blood lipid levels, have been further refined to provide better risk assessments. Certain specific parameters, such as lipoprotein buoyancy, seem to be better predictors of cardiovascular disease than total lipoprotein levels. Furthermore, as the contribution of systemic inflammation to the pathogenesis of atherosclerosis is increasingly recognized, several inflammatory markers have become associated with disease risk. Consequently, many studies have attempted to determine the individual merits of these factors in predicting cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Meredith Hawkins (2004) conducted a review in Cardiovascular disease and atherosclerosis. Lipoprotein buoyancy and inflammatory markers vs. Traditional measures such as total lipoprotein levels was evaluated on Cardiovascular disease risk prediction. Specific parameters like lipoprotein buoyancy and inflammatory markers appear to better predict cardiovascular disease risk than total lipoprotein levels.
Synapse has enriched 10 related papers. Consider them for comparative context: